Medicine
Dipyridamole 75 mg tablet
Dipyridamole 75 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Dipyridamole
- Brand
- Sold under the generic name
- Strength
- 75 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 7 more
- Manufacturers
- Zydus LifesciencesIndiaAmneal Pharmaceuticals of New YorkOxford Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC07 Dipyridamole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 May 2008
- Identifiers
- RxCUI 197622, 309952, 309955DailyMed set ID a18b2af5-7c4a-4b7f-92c7-8a76e34da373, 004bada0-dbf7-4a94-8792-6833d7eeda2b, 312aadb1-435c-4aa7-8e46-6506cedacaa0 +1NDC 0115-1072, 68382-189, 65841-664 +1Application ANDA040782, ANDA040874, ANDA040542
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 65841-664-01 | Zydus LifesciencesIndia | 22 May 2008 |
| 500 tablet, film coated in 1 bottle | 65841-664-05 | Zydus LifesciencesIndia | 22 May 2008 |
| 1000 tablet, film coated in 1 bottle | 65841-664-10 | Zydus LifesciencesIndia | 22 May 2008 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65841-664-77 | Zydus LifesciencesIndia | 22 May 2008 |
| 100 tablet, film coated in 1 bottle | 68382-189-01 | Zydus LifesciencesIndia | 22 May 2008 |
| 500 tablet, film coated in 1 bottle | 68382-189-05 | Zydus LifesciencesIndia | 22 May 2008 |
| 1000 tablet, film coated in 1 bottle | 68382-189-10 | Zydus LifesciencesIndia | 22 May 2008 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 68382-189-77 | Zydus LifesciencesIndia | 22 May 2008 |
| 100 tablet in 1 bottle | 0115-1072-01 | Amneal Pharmaceuticals of New York | 30 August 2021 |
| 100 tablet, film coated in 1 bottle | 69584-183-10 | Oxford Pharmaceuticals | 15 April 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 December 1961 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dipyridamole
Clinical summary
Dipyridamole is a platelet aggregation inhibitor indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately. MedsAcross supplies Dipyridamole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DipyridamoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dipyridamole prescribing information (Hikma Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Dipyridamole 75 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.